N-carbamylglutamate treatment for acute neonatal hyperammonemia in isovaleric acidemia
- PMID: 21207059
- DOI: 10.1007/s00431-010-1362-9
N-carbamylglutamate treatment for acute neonatal hyperammonemia in isovaleric acidemia
Abstract
Hyperammonemia occurs mainly in patients with branched-chain organic acidemias such as propionic, methylmalonic, and isovaleric acidemias. Its pathophysiological process is mainly via the competitive inhibition of N-acetylglutamate synthetase. Oral carglumic acid (N-carbamylglutamate) administration can correct hyperammonemia in neonates with propionic and methylmalonic acidemias, thus avoiding dialysis therapy. Isovaleric acidemia is an autosomal recessive disease of leucine metabolism due to deficiency of isovaleryl-CoA dehydrogenase. For the first time, we report a neonate with isovaleric acidemia, whose plasma ammonia concentration dropped dramatically after one oral load of carglumic acid. This experience suggests that carglumic acid could be considered for acute hyperammonemia resulting from isovaleric acidemia. However, trials with more patients are needed.
Similar articles
-
Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational study.Orphanet J Rare Dis. 2016 Mar 31;11:32. doi: 10.1186/s13023-016-0406-2. Orphanet J Rare Dis. 2016. PMID: 27030250 Free PMC article. Clinical Trial.
-
N-carbamylglutamate in emergency management of hyperammonemia in neonatal acute onset propionic and methylmalonic aciduria.Neonatology. 2010;97(3):286-90. doi: 10.1159/000255168. Epub 2009 Nov 4. Neonatology. 2010. PMID: 19887858
-
N-carbamylglutamate for neonatal hyperammonaemia in propionic acidaemia.J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S219-22. doi: 10.1007/s10545-008-0777-1. Epub 2008 Feb 21. J Inherit Metab Dis. 2008. PMID: 18338235
-
Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity.Am J Med Genet C Semin Med Genet. 2006 May 15;142C(2):95-103. doi: 10.1002/ajmg.c.30089. Am J Med Genet C Semin Med Genet. 2006. PMID: 16602101 Free PMC article. Review.
-
Presentation and management of N-acetylglutamate synthase deficiency: a review of the literature.Orphanet J Rare Dis. 2020 Oct 9;15(1):279. doi: 10.1186/s13023-020-01560-z. Orphanet J Rare Dis. 2020. PMID: 33036647 Free PMC article. Review.
Cited by
-
A Novel Method for Development and Validation of the Degradation Products Analysis of N-Carbamylglutamate with UHPLC by Using Design of Experiment Approach.ACS Omega. 2024 Sep 17;9(39):40346-40357. doi: 10.1021/acsomega.4c01183. eCollection 2024 Oct 1. ACS Omega. 2024. PMID: 39372016 Free PMC article.
-
Real-World Experience of Carglumic Acid for Methylmalonic and Propionic Acidurias: An Interim Analysis of the Multicentre Observational PROTECT Study.Drugs R D. 2024 Mar;24(1):69-80. doi: 10.1007/s40268-023-00449-z. Epub 2024 Jan 10. Drugs R D. 2024. PMID: 38198106 Free PMC article.
-
The significance of N-carbamoylglutamate in ruminant production.J Anim Sci Biotechnol. 2023 Apr 13;14(1):48. doi: 10.1186/s40104-023-00854-z. J Anim Sci Biotechnol. 2023. PMID: 37046347 Free PMC article. Review.
-
The glycine N-acyltransferases, GLYAT and GLYATL1, contribute to the detoxification of isovaleryl-CoA - an in-silico and in vitro validation.Comput Struct Biotechnol J. 2023 Jan 31;21:1236-1248. doi: 10.1016/j.csbj.2023.01.041. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 36817957 Free PMC article.
-
Compound heterozygote variants: c.848A > G; p.Glu283Gly and c.890C > T; p.Ala297Val, of Isovaleric acid-CoA dehydrogenase (IVD) gene causing severe Isovaleric acidemia with hyperammonemia.Mol Genet Metab Rep. 2022 Mar 19;31:100859. doi: 10.1016/j.ymgmr.2022.100859. eCollection 2022 Jun. Mol Genet Metab Rep. 2022. PMID: 35782626 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical